Comparison of influenza type A and B with COVID‐19: A global systematic review and meta‐analysis on clinical, laboratory and radiographic findings

@article{Pormohammad2020ComparisonOI,
  title={Comparison of influenza type A and B with COVID‐19: A global systematic review and meta‐analysis on clinical, laboratory and radiographic findings},
  author={A. Pormohammad and S. Ghorbani and A. Khatami and Mohammad Hossein Razizadeh and E. Alborzi and M. Zarei and J. Idrovo and R. Turner},
  journal={Reviews in Medical Virology},
  year={2020}
}
We compared clinical symptoms, laboratory findings, radiographic signs and outcomes of COVID‐19 and influenza to identify unique features. Depending on the heterogeneity test, we used either random or fixed‐effect models to analyse the appropriateness of the pooled results. Overall, 540 articles included in this study; 75,164 cases of COVID‐19 (157 studies), 113,818 influenza type A (251 studies) and 9266 influenza type B patients (47 studies) were included. Runny nose, dyspnoea, sore throat… Expand
Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City
TLDR
Influenza and COVID-19 have a similar picture in pediatric patients, which makes diagnostic testing necessary for adequate diagnosis and management, and the risk of death among hospitalized patients with comorbidities may be substantial, especially among infants. Expand
AKI in Hospitalized Patients with COVID-19 and Seasonal Influenza: A Comparative Analysis
TLDR
Pre-existing CKD was a major risk factor for AKI in both cohorts and African American race (independent of comorbidities) and mechanical ventilation were associated with a higher risk of developing COV-AKI which is characterized by a higher burden of stage 3 AKI and overall poorer prognosis. Expand
Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea
TLDR
Stroke, seizure, and impaired consciousness were significantly associated with severe to critical COVID-19, whereas headache and anosmia/ageusia were frequently found in patients with mild to moderate disease. Expand
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area
TLDR
During the first wave of the pandemic, admission to hospital for COVID-19 was associated with significantly greater mortality, ICU use and hospital length of stay than influenza. Expand
A comparison of coronavirus disease 2019 (COVID-19) versus influenza during the pandemic: Can we distinguish COVID-19 from flu?
TLDR
Older patients, male patients, patients reporting fever, and patients with higher body mass indexes (BMIs) were more likely to have COVID-19 than influenza. Expand
Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort
Objectives: Diagnostic work-up following any COVID-19 associated symptom will lead to extensive testing, potentially overwhelming laboratory capacity whilst primarily yielding negative results. WeExpand
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
TLDR
The significance of COVID-19 specific symptoms for triggering RT-PCR was confirmed and additional symptom combinations with optimal trade-offs between sensitivity and specificity that maximize case capture given different resource settings were identified. Expand
Just a bad flu? Tackling the “infodemic” in Ireland through a comparative analysis of hospitalised cases of COVID-19 and influenza
TLDR
COVID-19 is a more severe illness than seasonal influenza in hospitalised cohorts in most age groups and it is imperative that public health professionals ensure evidence-based advocacy is part of the response to CO VID-19 to tackle a dangerous “infodemic” which can undermine public health control measures. Expand
COVID-19 Prevention and Management : Overview
COVID-19 was originated from Wuhan city of Hubei Province in China in December 2019. Since then it has spread to more than 216 countries and territories. It is a contagious respiratory and vascularExpand
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
TLDR
Although there are many asymptomatic patients, one of the problems of COVID‐19 is early recognition of the disease, and an ARIA‐EAACI study group attempted to differentiate upper respiratory symptoms between the three diseases. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 47 REFERENCES
Clinical analysis of 150 cases with the novel influenza A (H1N1) virus infection in Shanghai, China.
TLDR
Considering the fact that the flu is highly infectious and can be carried through human to human contact rapidly, local Centers for Disease Control and prevention (CDC) should strengthen monitoring and take some measures in view of an influenza A (H1N1) onslaught. Expand
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
TLDR
An estimation of the clinical severity of COVID-19, based on the data available so far, can help to inform the public health response during the ongoing SARS-CoV-2 pandemic. Expand
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
TLDR
Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection. Expand
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
TLDR
Patients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posterior lungs on CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia. Expand
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
TLDR
Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Expand
[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
  • M. Q. Zhang, X. Wang, +5 authors X. Mu
  • Medicine
  • Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
  • 2020
TLDR
The patents with 2019 novel coronavirus pneumonia in this study generally have an epidemiological history and the clinical manifestations are fever and cough. Expand
[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
  • M. Q. Zhang, X. Wang, +5 authors X. Mu
  • Medicine
  • Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
  • 2020
TLDR
The patents with 2019 novel coronavirus pneumonia in this study generally have an epidemiological history and the clinical manifestations are fever and cough. Expand
[Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].
  • S. Bai, J. Wang, +4 authors F. Yang
  • Medicine
  • Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
  • 2020
TLDR
In this clustering outbreak of COVID-19, 4 patients remained asymptomatic, but PCR and IgM antibodies were positive, indicating that asymPTomatic patients may be the key point to control the epidemic. Expand
Kidney impairment is associated with in-hospital death of COVID-19 patients
TLDR
The prevalence of kidney impairment (hematuria, proteinuria and kidney dysfunction) in hospitalized COVID-19 patients was high and after adjustment for confounders, kidney impairment indicators were associated with higher risk of in-hospital death. Expand
Clinical characteristics of 2019 novel coronavirus infection in China
TLDR
The 2019-nCoV epidemic spreads rapidly by human-to-human transmission and the disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes. Expand
...
1
2
3
4
5
...